Ongoing Management of Opioid Use Disorder Medications: Emerging Research and Policy Challenges - Takeaways - MDSpire

Ongoing Management of Opioid Use Disorder Medications: Emerging Research and Policy Challenges

  • By

  • Stephan R. Lindner

  • Hillary Samples

  • April 22, 2026

  • 0 min

Share

  • 1

    MOUD treatment among Medicaid beneficiaries increased from 60.0% to 69.1% between 2019 and 2023, indicating improved access to care.

  • 2

    Despite increased MOUD treatment rates, 180-day retention in treatment declined from 62.6% to 57.6%, highlighting a need for improved continuity.

  • 3

    States with low MOUD treatment rates in 2019 saw significant increases, with Kansas and Arkansas tripling their rates by 2023.

  • 4

    Federal and state policy changes, such as removing prior authorization and allowing telehealth, aimed to expand MOUD treatment access.

  • 5

    Future efforts should focus on enhancing retention in MOUD treatment through care coordination, case management, and clinician education.

Original Source(s)

Related Content